24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Parkinson
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
12:00
NeuroKaire picks the right antidepressant by reading a blood sample
11:00
Factify builds an audit trail for enterprise AI agents making high-stakes decisions
10:00
Maolac turns cow colostrum into patented health ingredients
09:00
Kokomodo grows real cacao in a lab, no trees required
More stories
Buzz
Most popular
Daily
Weekly
1
Serbia opens Israeli drone factory as defense ties with Elbit deepen
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
4
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
5
Sayeret Matkal veterans raise $22 million to teach the world English with AI
More news
Parkinson
2 stories about Parkinson
Mitsubishi Tanabe Pharma Finalizes $1.1 Billion Buy of Israel-Based NeuroDerm
19.10.17
|
Lilach Baumer
NeuroDerm is looking to bring major change to Parkinson patients with its drug reformulation
Mitsubishi Tanabe Pharma to Buy Israel-Based NeuroDerm for $1.1 Billion
25.07.17
|
Gil Kalian
Osaka-based Mitsubishi Tanabe said it expects the deal would help it achieve sales of over $700 million in the U.S. by 2020
